Brain serotonin metabolism seems to be particularly gender-specific
There have been many research findings on links between
neurotransmitters, particularly serotonin, and gender differences in
aggressiveness. However, serotonin is known to play a role in many
body functions. These are temperature
regulation, sleep, mood, immune function, appetite, pain and the metabolic and behavioral
response to stress.
It appears that women have a slightly higher body
temperature than men. One investigation
had subjects consume a light non-protein breakfast before 8:00 AM, a cup of tea
or coffee after the 10:00 AM temperature collection, and a substantial 3-course
lunch at 1:00 PM. Results showed that
female temperatures were higher throughout the sample period. However, measurement of body temperature is
complicated, especially in women. Body temperature is influenced by
contraceptives and also by the menstrual cycle.
Furthermore, in women with
disturbed hormonal cycling (anorexics, high performance athletes), body temperature regulation is often
disturbed. As a matter strictly of
personal observation, it seems to me
that the women colleagues, students and employees I have frequented are much more
prone to complain of air temperature in air conditioned buildings, whether it be too hot or too cold. One recent study found that female rats
responded with greater body temperature changes to drugs known to mediate
hypothalamic control of body temperature than did male rats. Of course,
everybody knows that body temperature changes as a function of the
menstrual cycle: the thermometer is thus
often used to regulate sexual activity so as to favor or avoid
fertilization. In short, normal men’s and women’s body temperatures
seem to be very similar, but there could
be a basic sex difference in the adaptability of body temperature to endogenous
(internal) and exogenous (environmental) stimuli.
One team of investigators studied effects of age,
gender, diagnostic status, and psychiatric features on 102 female and 189 male
sleep disorder patients' (aged 16-87 years).
Gender had a strong impact, with women reporting more sleep-related
distress. It is noteworthy however that
the male clientele was more numerous, overall.
There are many types of sleep disorders. The most common one, perhaps also most closely related to
serotonin metabolism, is insomnia. There seem to be a bit more women than men
who suffer from insomnia. One study
surveyed 14,667 subjects (aged 20-54 years) in Norway about sleeplessness and
found that 41.7% of the women and 29.9% of the men were sometimes bothered by
insomnia. It has clearly been documented
that the proportion of rapid eye movement sleep (one of the phases of sleep
during which the eyeballs « jitter ») is modulated in mice as a
function of the menstrual cycle. Furthermore,
a few cases of clinical hypersomnia (a sleep disorder consisting of an
excessive need for sleep) have been reported to track the menstrual cycle in
afflicted women. However, normal sleep
is probably not directly influenced by sex hormones. Rather, I expect that the effect on sleep is
due to an influence of sex hormones on brain neurotransmitters. Serotonin seems to have a generally facilitatory
role in producing the type of deep sleep scientists call “slow wave sleep”. Indeed,
reserpine, a non-specific
serotonin antagonist, deprives animals
and humans of that type of sleep.
Another possible biological basis for a sex difference in sleep
patterns, in humans, might be found in
the pineal gland situated in the center of the brain. The pineal gland is light-sensitive and
secretes melatonin, a sleep inducing
hormone. One investigation compared
blood-melatonin concentrations in normal men and women exposed to hours of
darkness or of strong lights. In the
dark condition, no significant differences were observed between men and women
in either the timing or the absolute values of melatonin plasma levels, whereas
after bright light exposure, the suppression of plasma melatonin was 40%
greater in women than in men. These findings suggest that, in humans, there is
a sex difference in the nocturnal sensitivity of the pineal to light. It is nevertheless very difficult
(hazardous) to interpret sex differences in sleep disorders biologically: women have them relatively more in relation
to mood disorders, whereas men have them
relatively more in relation to substance abuse. Finally,
it is of note that variations in some basic parameters of sleep has been
found to track the menstrual cycle in normal women.
As I document in chapter 8, there is a huge sex difference in the immune
function -which could be mediated among other things by serotonin. Very little is known about this eventuality. Some anti-inflammatory drugs have a marked
serotonergic effect. Metabolic, physiologic and psychological effects of some
of those drugs vary according to sex.
For example, aspirin has an
antithrombotic effect (protects against strokes), but only in men. The inhibitory effect of
aspirin on blood platelets (the antithrombotic effect) was reduced in
orchiectomized (castrated) male patients and was restored by the addition of
testosterone to blood samples. Estradiol had no detectable influence on the
effect of aspirin on platelets.
Tricyclic antidepressants are selective serotonin agonists. The effect of one of them,
desmethylimipramine, on natural killer
lymphocytes (immune cells), is clearly inhibitory. One investigation went even further than
this: the authors found that in rats,
activation of the immune system by a toxin produces anhedonia (loss of the
subjective feeling of pleasure) and other depressive-like symptoms, which can
be attenuated or completely blocked by chronic treatment with an antidepressant
drug. An investigation of clinically
depressed humans found that several blood indicators of immune system
activation indicate immunostimulation during depression, and that this effect is counteracted by
tricyclic antidepressants. Of course, research on aspirin and antidepressants is
tangential to the issue of whether serotonin is a major factor in normal sex
differences in immune function, but it
weakly supports the idea. Chronic fatigue syndrome (CFS) is a condition that
affects women in disproportionate numbers, and that is often exacerbated in the
premenstrual period and following physical exertion. The signs and symptoms,
which include fatigue, myalgia (muscle pain), and low-grade fever, are similar
to those experienced by patients infused with cytokines such as
interleukin-1, drugs which influence
immune function. A study was recently
carried out to test the hypotheses that (1) cellular secretion of interleukin-1
beta (IL-1 beta), interleukin-1 receptor antagonist (IL-1Ra), and soluble
interleukin-1 receptor type II (IL-1sRII) is abnormal in female CFS patients
compared to age- and activity-matched controls; (2) that these abnormalities
may be evident only at certain times in the menstrual cycle; and (3) that
physical exertion (stepping up and down on a platform for 15 minutes) may
accentuate differences between these groups. Isolated peripheral blood
mononuclear cells from healthy women, but not CFS patients, exhibited
significant menstrual cycle-related differences in IL-1 beta secretion that
were related to estradiol and progesterone levels. IL-1Ra secretion for CFS
patients was twofold higher than controls during the follicular phase, but
luteal-phase levels were similar between groups. In both phases of the
menstrual cycle, IL-1sRII release was significantly higher for CFS patients
compared to controls. Candidal vaginitis
most often recurs during pregnancy and in the late luteal phase just before
menstruation. One study recently examined the influence of the stage of the
menstrual cycle on the cellular immune response to Candida albicans, the
efficiency of Candida albicans germination in blood serum, and the ability of
products from activated lymphoid cells (immune cells) to inhibit germination.
Candida albicans germination was maximal in blood sera obtained during the
luteal phase. During this period the cellular immune response to Candida was
reduced as was the inhibition of Candida germination by products of activated
peripheral blood mononuclear cells (another type of immune cell). Variations in
immune response to Candida were of much lesser magnitude in women who took oral
contraceptives, which suggests that it was the marked fluctuation in
progesterone or estradiol levels during the menstrual cycle that influenced the
changes in the immune response to Candida albicans. Thus the hormonal status of
women may influence the pathogenicity of Candida albicans by modulation of
immune system activity. The results of
this investigation explain the clinical observation that candidal vaginitis
infections most frequently reappear before menstruation. Several other investigations have found that
the strength of the immune response varies as a function of the menstrual
cycle.
The drugs most effective for combating mood disorders
also operate primarily along the serotoninergic axis, and women are much more
at risk for mood disorders. This issue
is reviewed in other chapters of this book.
So to make a long story short,
serotonin-based sex differences seem to include mood.
As for pain,
there seems to also exist a sex difference. Women’s thresholds for pain seem to be lower
than those of men for most forms of pain.
Women declare pain at lower intensities of stimulation, and declare higher subjective discomfort or
pain at equal levels of stimulation.
One test of pain that has been used to test this sex difference is
immersion of the hand into a bucket of ice-water. It could be argued of course that men just
have more bravado... and it is very
hard to judge whether subjective pain is a cultural artifact or not. One piece of evidence against an exclusively
culturalistic interpretation of a sex difference in pain threshold is the
finding to the effect that pain killers are reported by women to produce more
relief than by men. However, it might
be wise to keep in mind that there are many types of pain. For example, perhaps the kind of pain
encurred during childbirth would not be well tolerated by men... It is also relevant to think of pain
threshold reports of people according to a more fluid concept of sexual identity
than simple genotypic sex. Of course, what I mean here is the degree of androgyny
as measured by the appropriate type of personality scale. One study
investigated the relationship between measured levels of
masculinity-femininity, social desirability, and responsivity to pain in men
and women. A significant interaction was indeed found between
masculinity-femininity and sex for pain thresholds. Analysis of this
interaction indicated that for men, but not women, there was a significant
correlation between masculinity-femininity and pain, where higher masculinity
was associated with higher pain thresholds. However, this finding did not
account for the sex difference in pain threshold. The sex of the subject
remained a significant predictor of both pain thresholds and tolerances after
allowing for the influence of masculinity-femininity, social desirability, and
their associated interactions. At least
one study has found that women’s sensitivity to painful stimulation varies as a
function of the menstrual cycle.
Women are also more often victims of dysregulation of
appetite. Not only are there many more
anorexics (self-starvers) and bulimics (binge eaters) of the female sex (see
chapter 11), but women are also more
frequently obese. I suppose it could be
argued from a sociocultural perspective that if a person is going to abuse a
substance, if that person is a man, being acculturated to a position of
self-affirmation and of socializing outside the home -he will select
disreputable or illegal psychotropic (mind warping) drugs; if that person is a woman, she will stick to respectable and perfectly
legal abuse of a substance which is close to her social role of housewife: food.
However there are indications to the effect that female hormones do
modulate the brain’s regulation of appetite.
For example, athletics
(particularly long distance running) sometimes disturbs cycling of ovarian
hormones. In some particularly sensitive
or fragile women athletes, luteinizing hormone seems to be the first to be
reduced, followed by abnormality of the
gonadotropin cycle, and finally by a generalized drop in estrogen. Then amenorhea (loss of menses) occurs, followed by loss of appetite (anorexia). Investigations of normal women have found
that food intake varies as a function of the menstrual cycle.
Extreme stress is also known to inhibit the menstrual
process and prevent pregnancy in several species. The phenomenon is well known in rodents. When wild rabbits, for example, are environmentally stressed, particularly by food deprivation, they reproduce less -a mechanism the adaptiveness of which is
quite obvious. In women, extreme stress can stop the menstrual
process, make her temporarily
infertile, and disturb her mood, her thermoregulation, her sleep, and her appetite. The phenomenon was observed on a massive
scale during the despotic and murderous reign of Pol Pot and Ieng Sary in
Cambodia. Of course, it cannot be determined precisely to which extent
the drop in Cambodian women’s fertility during the years of terror was due to
psychocultural factors (less sexual activity,
attempts to avoid pregnancy) or
to psychobiological factors (hormonal imbalance, physiological infertility). In chapter 5, I argue that men are more
sensitive to stress than women (especially around birth), -except with regard to brain serotonin
physiology.
Post Comment
No comments